Boiron SA (BOIRF)
OTCMKTS · Delayed Price · Currency is USD
30.00
-1.86 (-5.85%)
At close: Nov 13, 2025
Boiron Revenue
Boiron had revenue of 245.65M EUR in the half year ending June 30, 2025, with 2.40% growth. This brings the company's revenue in the last twelve months to 504.86M, up 4.80% year-over-year. In the year 2024, Boiron had annual revenue of 487.56M, down -1.15%.
Revenue (ttm)
504.86M EUR
Revenue Growth
+4.80%
P/S Ratio
1.04
Revenue / Employee
184.52K EUR
Employees
2,736
Market Cap
613.90M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 487.56M | -5.69M | -1.15% |
| Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
| Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
| Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
| Dec 31, 2020 | 513.58M | -43.54M | -7.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |